<SEC-DOCUMENT>0001193125-20-029793.txt : 20200313
<SEC-HEADER>0001193125-20-029793.hdr.sgml : 20200313
<ACCEPTANCE-DATETIME>20200210161435
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001193125-20-029793
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20200210

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INOVIO PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001055726
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				330969592
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		6769 MESA RIDGE RD.
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		8584103134

	MAIL ADDRESS:	
		STREET 1:		6769 MESA RIDGE RD.
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INOVIO BIOMEDICAL CORP
		DATE OF NAME CHANGE:	20050404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GENETRONICS BIOMEDICAL CORP
		DATE OF NAME CHANGE:	20011116

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GENETRONICS BIOMEDICAL LTD
		DATE OF NAME CHANGE:	19980213
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>CORRESP</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g884075snap0002.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">February&nbsp;10, 2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><B>V<SMALL>IA</SMALL> E<SMALL>DGAR</SMALL></B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">United States Securities and Exchange Commission </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Division of Corporation Finance </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Office of Life Sciences </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">100 F Street, N.E. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Washington, D.C. 20549 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Ada D. Sarmento </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>RE:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Inovio Pharmaceuticals, Inc. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Filed January&nbsp;31, 2020 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>File No.&nbsp;333-236202 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Acceleration Request </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="78%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman"><B>Requested&nbsp;Date:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>February 13, 2020</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman"><B>Requested&nbsp;&nbsp;Time:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>4:00 P.M. Eastern Time</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the &#147;<B><I>Registrant</I></B>&#148;) hereby requests that the Securities and Exchange Commission take appropriate action to cause the
above-referenced Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (the &#147;<B><I>Registration Statement</I></B>&#148;) to become effective on February&nbsp;13, 2020, at 4:00 p.m., Eastern Time, or as soon thereafter as is
practicable, or at such later time as the Registrant may orally request via telephone call to the staff (the &#147;<B><I>Staff</I></B>&#148;) of the Division of Corporation Finance. The Registrant hereby authorizes each of Brian Leaf and Jeffrey
Libson of Cooley LLP, counsel to the Registrant, to make such request on its behalf. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Once the Registration Statement has been declared effective, please
orally confirm that event with Brian Leaf of Cooley LLP at (703) <FONT STYLE="white-space:nowrap">456-8053.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Inovio Pharmaceuticals, Inc.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Peter Kies</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Peter Kies</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Chief Financial
Officer</P></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">cc:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Brian Leaf, Cooley LLP </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Jeffrey Libson, Cooley LLP </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g884075g47k82.jpg" ALT="LOGO">
 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g884075g47k82.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g884075g47k82.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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ML$:3&4+^\*A"22<@9Q_,T 24 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M50">I ZT +M7!&T8/48ZT (L:(<JB@^PH =0 4 % !0 4 % !0 4 % !0 4
9% !0 4 % !0 4 % !0 4 % !0 4 % '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g884075snap0002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g884075snap0002.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1  (! @0$ P0'!00$  $"=P ! @,1
M! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_  !$( #P K@,!$0 "$0$#$0'_V@ ,
M P$  A$#$0 _ /?Z $R* %H * "@ H * "@ H * "@ H * "@ H 3(]: %!S
MTH * "@ H * "@!#P* /&-.D\7?\+3Q*;PI]J;S V_R?)S_WSC;T]Z /:!TH
M * "@ H * "@ H * "@ H * "@ H \Y^*[:^MC9?V5]H%H6;S_LVX/NXVYV\
MXZT =%X#.K'PE:'6O,^U9;'F_?V9^7=[XH Z2@ H * "@ H * ,:/Q7HDNLG
M1TOE;4 Y3R0K9R,DCICL: -6::.W@DGE;;'&I9CCH!R: ,:S\9^'K^WN;BWU
M2(PVP!E=@4"@YQU ST/2@#%/Q6\*B?R_M4VW.-_DMM^OK0!U]E?6NHVL=U9S
MI/!(,JZ'(- %B@!"P'7B@-C U#QIH6G2F%[SSIAU2W0RD?7;D#\:WC0G+8YY
M8BG#1E&#XE>&99Q#)=R6[GC]]"RC\\<?C6CP=5*]C-8RDW:YU-O=0742RV\R
M2QMT9&# _B*Y7%QW.J,E+9E#6/$>E:!Y)U2[%N)LA"48@XZ]!216Q<L;ZVU&
MSBO+.42V\J[D<="* +% &'#XOT&XUC^R8=05[[>8_*5&^\,Y&<8['\J +>K:
MYINA6Z7&IW(MXG;8K%2<G&<<#T% %FQOK;4K**\LY!+;RC<C@$9'XT 3E@HR
M>![T <KJGQ&\,Z5<M;RW_FRKPP@0N!^(XH FT?Q[X=UJ?[/;7X2?M',I0M]"
M>#^% '2 T +0 'I0!XEIG'QQD';[9-_Z ] 'K^M?\@'4/^O:3_T$T >"> O#
M0\4:Q)93S/'90J)IE0XW8.%'ZGGZT >HZG\+O#<^FR16=HUO<[#Y<JRL<-CC
M()P10!R_P=O[B'5=2TB5CL\OS0F<A65@K?S'Y4 >F:[KMEX>TYKV^<K&"% 4
M99CZ 5I2I3K2Y8F56M"C'FD9FCZMIOC6T::(R&UB?;);R+MRW7YN3D>W3UJZ
MM*>'=I&=*K#$*\3HHH(H(Q'#&L<8Z*HP!6#;>YORI;%+5=%T[6;5K>_M8YD8
M8RP^9?<'J#5PJ3IN\61.E"JK21XX\NH_#'Q@8HY&FLG ;;VDC)]/[PP:]OW<
M;2VU1XBY\%5L]CTCQ;IMOXN\$/):@2N8Q<VS8YR!D#\1D?C7ARBX-Q9[L)*4
M5)',?!S6S+;7FC2R9,7[^$'^Z>&'YX/XU)9VWC#7U\.>'+J]# 3[=D /=ST_
M+K^% '!?"+0&DFN?$5T&+',4!/\ $3]]OZ?G0!J?&/CPS9'_ *>Q_P"@-0!T
MO@+CP+H__7 4 <1\2O$UY=ZK'X5TLL&8JLQ4_P"L9L;4^G()^M &KH/PFT:T
MLHSJZM>WA'S[9&6,'T&,$_C0!5\3?">QFLS-H -O<J,^2[EDD]LGD&@!WPN\
M63WBOX?U)G-U;*3"S=2HX*GW'\OI0!Z90 'I0!XEIG_)<I/^OR;_ - :@#U_
M6O\ D ZC_P!>TG_H)H \L^"JC[;K+8Y\N(?JU 'L!Z4 >,?#3CXD:F!_<G_]
M&+0!J?&:23R='A&?+9I6([$@*!_,UZV6)<S/(S-NR.D^&=E!:^"K22)1ON"T
MDC?WFR1_( ?A7)C9-UW<Z<#%*BK'85R'<(: /&OC!=P2:Y8VJ$&6"$F0CMN(
MP#^6?QKVLLC:#;/"S*5YI(]%\$121>"=(28$-]G4X/7!Y'Z5Y>(LZLFCU<*F
MJ44SR[Q);R^ _B)#J=JA%I,WG*J< J>'3]3Q[BL3H+/Q)UG_ (277--T;2G\
M]5 ("GAI'QC\E/ZF@#UK1-,CT;1K33XAA8(PN?4]S^)R: .(^,G_ "+-E_U]
MC_T!J .D\!_\B+H__7N* /,TQ_PO/_2<?\?C=?\ <.S_ -EH ]N'2@!#0!XG
MX:*_\+KG%O\ ZO[3<].F,/\ IG% 'MM  >E 'B>F _\ "\I#@X^V3?\ H#4
M>NZT0-!U#G_EVD_]!- 'E_P5_P"/K6?]R+^;T >O'I0!XO\ #3_DI&I_[D__
M *,6@#T#QUX7;Q/HGDP,%NX#YD)/0G^Z?K75A:_L:ESDQ5'VT+(X?P#XO_X1
MR:7P]K:M;QI(=LC\"(]U;V)[UWXO#NJO:P//PF(5%^RF>N0S1SQ++%(LD;#(
M93D'\:\9IK1H]I-/5,@O]2M-.1&NIUCWMM0'DN?0#J3["JC&4MB93C'<YG4O
M >E^(=8CUF]6>*5@N^%7&UP.F[C@_0UTPQ,Z4'!'-/"PJR4V=@JA$"J, #
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M8\_@./TH ETSP'X:TEUDM],C>5>0\Q,A'TSP* .C QC% "T % !0 4 % !0
@4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
